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أنواع البكترييا املرتبطة باإلنتان الوليدي يف مستشفى 
جامعة الثورة، صنعاء ، اليمن وشاكلة مضادات 
امليكروبات
ح�سن عبد الوهاب ال�سماحي، اأمل عبد الكرمي �سربة، عبدالباقي عبداهلل الربا�سي، �سمرية مثنى نا�رص
امللخ�ص: الهدف: حتديد البكترييا امل�سببة لالإنتانات بني حديثي الولدة يف م�ست�سفى الثورة مبدينة �سنعاء، بالإ�سافة اإىل حتديد مقاومة 
البكترييا للم�سادات احليوية، وو�سع تو�سية للعالج التجريبي بناء على ذلك. الطريقة: ت�سمنت هذه الدرا�سة 158 طفال حديثي الولدة 
)ترتاوح اأعمارهم بني 0 و28 يوما(عانوا من واحد اأو اأكرث من اأعرا�س الإنتانات. مت اأخذ عينة من الدم الوريدي من كل احلالت، وثم مت 
واأظهرت   ،)75%( 09 طفال  يف  اإيجابيا  اجلرثومي  الزرع  فح�س  كان  النتائج:  املعزولة.  للجراثيم  احل�سا�سية  اختبارات  وحتديد  زرعها 
اإ�سابات الإنتان املبكرة اأعلى النتائج الإيجابية للزرع اجلرثومي )%61.7( منه يف الإ�سابات املتاأخرة )%32(. وجدت نتائج الزرع 
البكترييا �سالبة  2 كيلو جرام )%78.6(. �سّكلت  0.9 اإىل  الولدة بني  الذين يرتاوح وزنهم عند  الأطفال  اليجابي املهمة عند جمموعة 
ال�سائدة فيها بن�سبة )%36.7(، تليها  اإجمايل الزرع اجلرثومي، حيث كانت بكترييا الكلب�سيلة الرئوية هي  اجلرام ن�سبة )%97.8( من 
اأكرث الأعرا�س �سيوعا بني امل�سابني فكان �سيق التنف�س بن�سبة )%72.2( من احلالت، تالها  اأما  اِئَفة بن�سبة )30.0%(.  الزَّ البكترييا 
البكرتيا �سالبة  الزرع لكل  الوفيات فبلغ )%27.8(. كانت نتائج  اأما معدل  الريقان )%62.2( والُزراق )%51.1( والُنوام )47.8%(. 
ُمقاومة لأكرث  الزرع كانت  نتائج  ال�سيفالو�سبورين، لكن معظم  الرابع من  للجيل  اميبينيم، وبع�سها كان ح�سا�سا  للدواء  اجلرام ح�سا�سة 
الولدة يف مدينة  البكتريية حلديثي  لالإنتانات  الرئي�سية  امل�سببة  �سالبة اجلرام هي  البكترييا  اخلال�صة:  امل�ستخدمة.  امل�سادات احليوية 
�سنعاء، وكانت �سببا رئي�سيا يف الوفاة واملر�س حلديثي الولدة، خا�سة بني املواليد ذوي الوزن املنخف�س جدا. ميكن ال�ستنتاج باأن 
امل�ساد احليوي اميبينيم واجليل الرابع من ال�سيفالو�سبورينات ميكن اأن تكون اخليار الأول للعالج التجريبي للحالت املر�سية بالإنتان 
البكتريي .
مفتاح الكلمات: اأنتان، وليدي، مبكر، متاأخر، مقاومة دواء، عالج، عالج جتريبي، �سنعاء، اليمن.
abstract: Objectives: This study was undertaken to investigate the organisms causing sepsis in the Neonatal Unit 
at Al-Thawra Hospital, Sana’a, Yemen, determine their resistance to antibiotics, and recommend policy for empirical 
treatment. Methods: A total of 158 neonates having one or more signs of sepsis, and aged from 0 to 28 days, were 
enrolled in this study. A blood sample was taken from each subject, cultured, and then antibacterial susceptibility 
tests were performed for isolates. Results: 90 (57%) cases yielded positive cultures. Early-onset sepsis showed higher 
positive culture results (61.7%) than late-onset sepsis (32%). Significant positive culture results were found among 
the group with birth weight 0.9–2 Kg (78.6%). Gram negative bacteria constituted 97.8% of the total isolates, of 
which Klebsiella pneumoniae was the predominant pathogen (36.7%), followed by Pseudomonas species (30.0%). 
The commonest symptoms among the cases were respiratory distress (72.2%), jaundice (62.2%), cyanosis (51.1%), 
and lethargy (47.8%); the mortality rate was 27.8%. All Gram negative bacterial isolates were sensitive to imipenem 
and some isolates were sensitive to fourth-generation cephalosporins, but most isolates were highly resistant to the 
majority of other antibiotics tested. Conclusion: Gram negative organisms were the most frequent causative agents 
of bacterial sepsis, which is a significant cause of mortality and morbidity in the newborn, and particularly in those 
of very low birth weight. It can also be concluded that imipenem and fourth-generation cephalosporins can be used 
for empirical treatment of bacterial sepsis.
Keywords: Sepsis; Neonatal; Early-onset; Late-onset; Drug resistance; Treatment, empirical; Sanaa; Yemen. 
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Sepsis is a significant cause of mortality and morbidity in the newborn, particularly among those of very low birth 
weight and premature infants.1,2 The World Health 
Organization (WHO) estimates that worldwide 
1.6 million newborn babies die every year from 
neonatal infections. Individual units have reported 
case fatality rates as low as 2–3% and as high as 50%,3 
but the average overall mortality from neonatal 
sepsis reported from many neonatal intensive 
care units in developed countries is around 20%.4 
Despite recent advances in neonatal intensive care 
and current strategies to treat neonatal sepsis, 
mortality rates have not fallen for over three 
decades4 except in babies born to mothers who 
have received intrapartum prophylaxis (IAP) for 
Group B Streptococcus (GBS).5 Whilst IAP has been 
successful in significantly reducing the incidence 
of early onset GBS disease in the newborn it has 
led to an increase in Gram negative infections in 
institutions where antibiotics other than penicillin 
are used for IAP.6 Worryingly, both short and 
long term neurodevelopmental morbidity in 
survivors of neonatal sepsis is also significant.7 The 
study by Stoll et al. in 2002 showed that neonatal 
infection is associated with a 30–80% increase in 
neurodevelopmental impairment and a 30–100% 
increase in odds for poor head growth which is a 
very good predictor of long-term morbidity.6 
This study aimed to determine the types of 
bacteria associated with neonatal sepsis in neonatal 
unit of Al-Thawra University Hospital in Sana’a, 
Yemen, and their antibiotic profile. 
Methods 
This prospective study was carried out during a 12 
month period from April 2008 to March 2009. The 
study proposal was approved by the Department of 
Medical Microbiology, in the Faculty of Medicine 
& Health Sciences at Sana’a University, Yemen. A 
total of 158 hospital-born neonates with a clinical 
diagnosis of septicaemia, and admitted to the 
neonatal unit of Al-Thawra University Hospital in 
Sana’a city, were included in this study. A consent 
form was completed by the parents for each subject.
Early-onset sepsis (EOS) was defined as sepsis 
occurring within the first week of life.  Late-onset 
sepsis (LOS) was defined as sepsis that occurred 
any time after the first week of life until the end of 
the neonatal period (28 days of age). A full history 
was taken from doctors and files, and the findings 
were recorded in a predesigned questionnaire. The 
data collected included: any complications during 
delivery, characteristics of the infant, sex, birth 
weight, temperature, other medical conditions in 
the infant, major signs and symptoms and other 
necessary data for the research. Blood culture was 
preformed for all neonates suspected of having 
septicaemia. Septicaemia was suspected in the 
following settings: 1) At birth: All neonates born to 
mothers with maternal fever, prolonged rupture of 
membranes for more than 24 hours, or foul-smelling 
or meconium-stained liquor, and those having 
severe prematurity or birth asphyxia necessitating 
active resuscitation; 2) After birth: All newborns 
with lethargy, poor feeding, abdominal distension, 
respiratory distress, instability in temperature, 
pathological jaundice, and convulsions.
The collected data and the results of this study 
were statistically analysed for means of significance 
by the Epi Info computer programme, Version 6 (Epi 
Info, Centers for Disease Control (CDC), Atlanta, 
Georgia, USA). The specimens were collected as 
follows: one blood culture at least was obtained for 
each neonate with signs of sepsis, by the method 
described by Buttery.8 Blood from peripheral 
venous or arterial punctures was collected under 
sterile conditions as described by Hall and Lyman.9 
The blood specimen was then inoculated into a 
BACTEC vial (BACTEC, Rochester, UK) and the 
Advances in knowledge 
1. This study provides current data on the organisms causing sepsis in neonatal units and the resistance of the sepsis-causing organisms to the 
relevant antibacterial drugs. It was found that Gram negative organisms were the most frequent causative agents of bacterial sepsis (97.8%).
2. This information is important in order to recommend policy for empirical treatment. 
3. This is one of only a few studies from Arabic countries focused on neonatal sepsis. 
Application to patient care 
1. The research reported here could aid in the prevention of neonatal sepsis and build a treatment policy for neonatal bacterial sepsis. 
2. This study alerts physicians to the defective hygiene in neonatal units and the high rate of resistance to antibiotics.
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inoculated culture bottles were incubated as soon 
as possible in the BACTEC brand fluorescent 
series instrument (BACTEC 9120) for up to 5 
days, as recommended by Becton Dickinson 
Microbiological Systems.10 Positive blood culture 
vials were sub-cultured into blood agar, chocolate 
agar, MacConkey agar, and Sabouraud agar (for 
yeast), then the media were inspected for the 
presence of bacterial growth. The isolated bacteria 
were defined by colonial morphology, Gram stain 
reaction, biochemical reactions and confirmed 
by API-20E biotyping (API 20E system, Analytab 
Products, Plainview, New York, USA). Finally, the 
sensitivity of isolated bacteria to various antibiotics 
was assessed according to the modified Kirby 
and Bauer method on Mueller-Hinton agar. The 
concentrations of the antibiotics used (µg/disc) 
were as follows: ampicillin (AMP) ˗ 10; gentamycin 
(CN) ˗ 10; amikacin (AK) ˗ 30; ceftazidime (CAZ) 
˗ 30; ceftriaxone (CRO) ˗ 30; cefepime (FEP) ˗ 30; 
piperacillin (P) ˗ 100; imipenem (IPM) -10; and 
aztreonam (ATM) ̠  30. The Clinical and Laboratory 
Standards Institute (CLSI) guidelines were used to 
determine antimicrobial resistance. 
Results
This study included 158 neonates, their ages ranging 
from 0 to 28 days with a mean age of 5.2 days.
The standard deviation (SD) was equal to 
6.1 days, mode equal to 1 day and median equal 
to 3 days. There were 96 (60.8%) males and 62 
(39.2%) females. The detailed results of this study 
are presented in Tables 1 to 6. Table 1 shows the 
distribution of positive bacterial culture according 
to sex. A total of 90 (57%) of patients had a 
positive culture for bacterial growth. The rate of 
positive culture among females (62.9%) was higher 
compared to males (53.1%), but the variation was 
not statistically significant in which χ2 = 1.47 and 
P = 0.22. The EOS showed higher positive culture 
results (61.7%) than LOS (32%), with the relative 
risk of contracting EOS bacterial infection 2.2 
times that of LOS, but the difference was not 
statistically significant in which χ2 = 2.7 and P = 
0.1 [Table 2]. Table 3 shows that highly significant 
positive cultures results were found among the 
group with birth weight 0.9–2 Kg (78.6%, χ2 = 5.7, 
P = 0.01). The commonest symptoms among the 
cases studied were respiratory distress (72.2%), 
jaundice (62.2%), cyanosis (51.1%) and lethargy 
(47.8%). On the other hand, lethargy, apnoea, poor 
feeding and unconsciousness occurred significantly 
less frequently among positive bacterial culture 
cases in which χ2 > 3.7 and P <0.05. However, the 
mortality rate was higher among positive culture 
cases (27.8%), than negative ones (2.9%) and the 
variation was statistically significant in which χ2 = 
16.86 and P = 0.0004 [Table 4]. 
Table 1: The rate of positive bacterial culture among 
male and female neonates.




No. % No. %
Male  96 60.8 51 53.1 1.47 0.22
Female 62 39.2 39 62.9
Crude rate 158 100.0 90 57
Legend: χ2 = chi square; P = probability value.
Note: χ2 > 3.7 and P <0.05 are significant.
Table 2:  The rate of positive bacterial culture in early-
onset (EOS) and late-onset of sepsis (LOS) and their 
relative risks for contracting bacteria, confidence 






RR CI χ2 P
No. %
EOS ≥ 7 days
n =133
82 61.7 2.2 (0.77–6.3) 2.7 0.10
LOS < 7 days
n = 25
8 32 0.7 (0.4–1.2) 2.7 0.10
Total 90 57
Legend: RR = Relative risk; CI = Confidence Interval; χ2 = chi square, P 
= probability value
Note: χ2 > 3.7 and P < 0.05 are significant
Table 3: The rate of positive bacterial culture and its 








No. % No. %
0.9–2 73 46.2 50 68.5 5.7 0.01
2.1–3 63 39.9 31 49.2 3.7 0.05
3.1–4 19 12 08 42.1 0.2 0.68
<4 3 1.9 1 33.3 0.7 0.4
Legend: χ2 = chi square; P = probability value.
Note: χ2 > 3.7 and P <0.05 are significant
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Gram negative bacteria constituted 97.8% of the 
total isolates, of which Klebsiella pneumoniae was 
the predominant pathogen with 36.7%, followed 
by Pseudomonas species with 30.0%. Citrobacter 
species was the least common isolate of Gram 
negative bacteria with a percentage of 4.4%, while 
Gram positive bacteria rates were very low (1.1%) 
[Table 5]. All Gram negative bacterial isolates were 
sensitive to imipenem and some isolates were 
sensitive to fourth-generation cephalosporins 
(cefepime), but most isolates were highly resistant 
to the majority of other antibiotics tested [Table 6]. 
Discussion
In this study, blood culture obtained from 158 
neonates yielded positive results in 57% of cases, 
while the remaining 43% gave negative results. A 
similar result was reported by Ako-Nai and others 
in Nigeria in 1999 with a positive percentage of 
55%.11 Slightly higher positive results were reported 
by Rohsiswatmo (65.3%) in Indonesia,12 Rahman et 
al.13 in Pakistan (62.8%) and by Macharashvili et al. 
14 in Georgia (63%). In contrast, much lower positive 
results were reported from Iran (5.6%),15 Kuwait 
(8.7%)16 and Saudi Arabia (5%).17 These variations 
can be attributed to many different factors of which 
antibiotic therapy prior to the laboratory diagnosis 
may have had the most important influence on the 
low culture results. 
The EOS rates (61%) were higher than the LOS 
rates (32%) in this study. This result is compatible 
Table 4: Presenting clinical symptoms and mortality rate among total patients compared with positive bacterial 
culture.





No. % No. %
Fever, n = 20 8 11.8 12 13.3 0.09 0.76
Lethargy, n = 64 21 31 43 47.8 4.6 0.03
Jaundice, n = 98 36 53 56 62.2 0.00 0.95
Apnoea, n = 15 3 4.4 12 13.3 3.6 0.05
Respiratory distress, n = 116 51 75 65 72.2 0.15 0.7
Poor feeding, n = 19 2 2.9 17 18.9 9.3 0.002
Cyanosis, n = 76 30 44.1 46 51.1 0.76 0.38
Abdominal distention, n = 7 4 5.8 3 3.3 0.6 0.4
Pallor, n = 20 5 7.3 15 16.7 3.04 0.08
Convulsion, n = 5 1 1.5 4 4.4 1.12 0.29
Birth asphyxia, n = 8 4 5.9 4 4.4 0.17 0.68
Unconscious, n = 21 5 7.3 16 17.8 3.65 0.05
Mortality rate, n = 27 2 2.9 25 27.8 16.86 0.0004
Legend: χ2 = chi square; P = probability value.
Note:  χ2 > 3.7 and P <0.05 are significant
Table 5:  The frequency and percentage of bacterial 
species that isolated from neonate sepsis cases
Organism No. %
Gram negative bacteria 88 97.8
Klebsiella pneumoniae 33 36.7
Pseudomonas species 27 30
Enterobacter species 14 15.6
Acinetobacter species 10 11.1
Citrobacter species 4 4.4
Gram positive bacteria 1 1.1
Staphylococcus aureus 1 1.1
Fungi 1 1.1
Candida species 1 1.1
Total positive bacteria 90 100.0
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with the reports from Iran and Pakistan,18,19 but it 
contrasts with a report from Bangladesh, where LOS 
was more common than EOS.20 However, the most 
common organism in EOS was K. pneumoniae; 
the same finding was recorded in many developing 
countries.21–23 In the present study, females showed 
slightly higher positive results than males, which is 
similar to findings reported from Iran.24
The commonest symptoms among the cases 
studied were respiratory distress (72.2%), jaundice 
(62.2%), cyanosis (51.1%, and lethargy (47.8%). On 
the other hand, lethargy, apnoea, poor feeding and 
unconsciousness showed significantly low rates of 
occurrence among positive bacterial culture cases. 
In general, the presenting clinical symptoms and 
signs in our study agreed with the WHO clinical 
criteria for neonatal sepsis.25
There was a significant correlation between low 
birth weight and the incidence of neonatal sepsis 
with, statistically significant values of χ2 = 5.7 
and a P value equal to 0.01. The same finding was 
observed in the studies of Al-Umran and Twum-
Danso in Saudi Arabia and Jeong in Korea.17,26 
Mortality rate among positive culture cases in this 
study was 27.8%, which was similar to that found in 
Zimbabwe,27 Pakistan28 and Georgia.14 
The most common organisms which caused 
EOS and LOS in the present study were Gram 
negative bacteria, with a percentage of 97.8%. This 
result agreed with other related studies in many 
developing countries,13,14,23,29 but differed from 
those reported by Huda et al.16 in Kuwait, Haque et 
al.4 in the UK and Hyde et al.30 in the USA where 
Gram positive bacteria were more predominant. 
K. pneumoniae was the predominant isolate in the 
present study, representing 36.7% of the total isolates. 
Similar findings were reported by Macharashvili in 
Georgia,14, Mehdinejad et al. in Iran (33.5%)15 and 
by Kumhar et al. in India (33.8%),21 but lower results 
were reported from Nepal (18.3%) and Pakistan 
(7.6%).31,13 Moreover, it was found in this study 
that Pseudomonas species were the second most 
common isolate; similar findings were reported in 
Pakistan.13,32 The overwhelming majority of Gram 
negative organisms isolated in this study and among 
the other studies reviewed suggests that these 
infections may in fact be acquired from the hospital 
or community environment, due to poor hygienic 
practices during delivery and postnatal care, rather 
than reflecting vertical transmission to the infant 
from exposure to vaginal tract flora.33,34  Another 
possible explanation of the predominance of Gram 
negative bacteria in our study is that asymptomatic 
colonised patients, the contaminated environment, 
or both can serve as reservoirs for these pathogens, 
which are then spread by the hands of health care 
workers.35,36 Furthermore, a limitation of our study 
was that there is insufficient sterility testing or 
wipe testing of the neonatal wards to confirm if the 
conditions are unhygienic which could mean that 
contaminating bacteria might also be recovered 
from the environment. 
Table 6:  Resistant pattern of the isolates to some antibiotics









AMP 29 (87.8) 23 (85.2) 12(92.3) 3 (75.0) 5 (50)
AML 31 (93.9) 19 (70.3) 13 (100) 4 (100) 9 (90)
ATM 30 (90.9) 20 (74.0) 10(76.9) 4 (100) 7 (70)
PRL 29 (87.8) 3 (11.1) 8 (61.5) 1 (25.0) 1 (10)
CAZ 30 (90.9) 10 (37.0) 12(92.3) 4 (100) 5 (50)
FEP 12 (36.4) 4 (14.8) 0 1 (25.0) 0 
CRO 32 (96.9) 19 (70.3) 13 (100) 4 (100) 9 (90)
IPM 0 0 0 0 0
AK 13 (39.3) 12 (44.4) 8 (61.5) 0 5 (50)
CN 9 (27.2) 17 (62.9) 5 (38.4) 0 5 (50)
Legend: AMP = ampicillin; AML = amoxicillin; ATM = azteronam; PRL = pipracillin; AK = amikacin; CN = gentamicin; CAZ = 
ceftazidim; CRO = ceftriaxon; FEP = cefipime = c; IPM = imipenem. 
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Multi-drug resistance of the causative 
organisms of sepsis is a rapidly emerging and 
potentially disastrous problem. Infection with 
resistant organisms has been associated with 
treatment failure, higher morbidity and mortality 
and increased costs. The present study shows a 
very high degree of resistance of Gram negative 
organisms to commonly used antibiotics (AMP and 
CN) as well as third-generation cephalosporins. 
These results agree with many other studies.12,18,37,,38 
The high burden of infection and the degree of 
antibiotic resistance seen in this study population 
may signify an emerging trend among sepsis isolates 
recovered from neonates in developing countries. 
In a review of data from developing countries, 
Zaidi et al. found rates of neonatal infection in 
hospitalised infants to be 3–20 times higher than 
those in developed countries, and approximately 
70% of these infections would not be susceptible to 
conventional empirical antibiotic regimens, such as 
AMP with CN.39 
All Gram negative organisms in this study were 
sensitive to IMP; the same results were reported by 
Shaw et al., Al-Tawfiq and Antony, Rohsiswatmo, 
and Waseem et al.31,40,12,23 In contrast, a study in the 
Philippines reported 20% resistance to IMP.36 In 
the present study, there was increasing resistance 
to third-generation cephalosporins, probably 
attributable to extended spectrum beta-lactamase 
(ESBL) production by Gram negative bacteria, 
especially Klebsiella, as also observed in another 
studies on neonates. 31,39,41 The lack of culture-
driven antimicrobial therapy and limited, consistent 
infection control practices is likely to be responsible 
for the resistance of Gram negative organisms in 
this study. 
Conclusion
Gram negative organisms were the most common 
causative agents of bacterial sepsis in this study. In 
turn, they are a significant cause of mortality and 
morbidity in the newborn, particularly in very low 
birth weight infants. IPM and fourth-generation 
cephalosporins such as FEP can be used for the 
empirical treatment of bacterial sepsis in Sana’a city, 
Yemen.
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